5月8日より、得得！決算セール！決算プライス！に５万円ご購入クーポン付き！
2025年05月07日
5月8日より、得得！決算セール！決算プライス！に５万円ご購入クーポン付き！ガラスコーティング付き無料！
☆決算セール！ご購入サポートクーポン付き！この季節、新しくクルマ購入をご検討のお客様へ お得な特典クーポンをご用意しております！詳しくはお問合せ下さい！※他特典重複不可
セール期間中 ボディーガラスコーティング無料！
全車納車前点検整備付き(認証工場法定点検整備・認証法定記録簿付き)
この記事へのコメント
(Wilhemina)
When To Take Anavar: Before Or After Workout?
Metabolit ? a generic name for the anabolic?androgenic steroid known as metandro (often sold under brand names such as Metandien or
Metandrol)
> Note: The following information is provided for educational purposes only.
It is not intended to replace professional medical advice, diagnosis, or treatment.
---
1. What Is Metandrol?
Metandrol (also called "metandro") is a synthetic derivative of testosterone that has been used in some
countries as an anabolic steroid to treat conditions
such as muscle wasting, osteoporosis, and anemia. In the past it has also
appeared on the black market for body?builders and athletes
looking to increase lean muscle mass and improve athletic performance.
Aspect Details
Drug class Anabolic?androgenic steroid (AAS)
Mechanism of action Binds to androgen receptors, stimulating protein synthesis, nitrogen retention,
and cell proliferation.
Clinical uses Rarely used in modern medicine; historically for muscle wasting, osteoporosis, anemia.
Legal status Schedule III controlled substance in the U.S.;
illegal without prescription.
---
2. Key Pharmacology
2.1 Pharmacodynamics
Androgen receptor (AR) activation: Enhances transcription of genes related to muscle growth.
Estrogenic conversion: Dihydrotestosterone (DHT), a metabolite, can be aromatized into estradiol, influencing bone density and fat metabolism.
2.2 Pharmacokinetics
Parameter Typical Value
Absorption Oral: ~70% bioavailability due to first?pass hepatic metabolism
Distribution Volume of distribution ? 1?2 L/kg; lipophilic, crosses membranes
Metabolism Hepatic CYP3A4 (major), also via UDP?glucuronosyltransferases
Elimination Half?life ~4?5 hours; excreted mainly as glucuronide conjugates in urine
Clearance 2?3 L/h/kg
2.3 Clinical Implications
Drug?drug interactions: Strong inhibitors or inducers of CYP3A4 can alter drug levels dramatically.
Patient variability: Genetic polymorphisms (CYP3A5, UGT1A9) affect metabolism and response.
Therapeutic monitoring: Plasma concentration?effect relationships guide dose adjustments.
6. Conclusion
The pharmaceutical industry has evolved from a focus
on single?molecule "magic bullet" drugs to sophisticated, multi?target therapeutics
that leverage detailed mechanistic insights into drug
action. Modern drug discovery is guided by systems biology, high?throughput screening, and personalized medicine approaches, while regulatory pathways
now require robust evidence of safety, efficacy, and manufacturing quality.
Understanding pharmacokinetics, particularly absorption and metabolism, remains essential
for optimizing therapeutic regimens and ensuring patient safety.
---
References
"Drug Discovery & Development." National Institutes of Health, 2023.
"Pharmacokinetic Principles." FDA Guidance for Industry, 2019.
"Multi-Target Drug Design." Journal of Medicinal Chemistry,
vol. 65, no. 14, 2022, pp. 5431?5445.
"Personalized Medicine and Pharmacogenomics." Nature Reviews Drug Discovery, vol.
21, 2020.
Metabolit ? a generic name for the anabolic?androgenic steroid known as metandro (often sold under brand names such as Metandien or
Metandrol)
> Note: The following information is provided for educational purposes only.
It is not intended to replace professional medical advice, diagnosis, or treatment.
---
1. What Is Metandrol?
Metandrol (also called "metandro") is a synthetic derivative of testosterone that has been used in some
countries as an anabolic steroid to treat conditions
such as muscle wasting, osteoporosis, and anemia. In the past it has also
appeared on the black market for body?builders and athletes
looking to increase lean muscle mass and improve athletic performance.
Aspect Details
Drug class Anabolic?androgenic steroid (AAS)
Mechanism of action Binds to androgen receptors, stimulating protein synthesis, nitrogen retention,
and cell proliferation.
Clinical uses Rarely used in modern medicine; historically for muscle wasting, osteoporosis, anemia.
Legal status Schedule III controlled substance in the U.S.;
illegal without prescription.
---
2. Key Pharmacology
2.1 Pharmacodynamics
Androgen receptor (AR) activation: Enhances transcription of genes related to muscle growth.
Estrogenic conversion: Dihydrotestosterone (DHT), a metabolite, can be aromatized into estradiol, influencing bone density and fat metabolism.
2.2 Pharmacokinetics
Parameter Typical Value
Absorption Oral: ~70% bioavailability due to first?pass hepatic metabolism
Distribution Volume of distribution ? 1?2 L/kg; lipophilic, crosses membranes
Metabolism Hepatic CYP3A4 (major), also via UDP?glucuronosyltransferases
Elimination Half?life ~4?5 hours; excreted mainly as glucuronide conjugates in urine
Clearance 2?3 L/h/kg
2.3 Clinical Implications
Drug?drug interactions: Strong inhibitors or inducers of CYP3A4 can alter drug levels dramatically.
Patient variability: Genetic polymorphisms (CYP3A5, UGT1A9) affect metabolism and response.
Therapeutic monitoring: Plasma concentration?effect relationships guide dose adjustments.
6. Conclusion
The pharmaceutical industry has evolved from a focus
on single?molecule "magic bullet" drugs to sophisticated, multi?target therapeutics
that leverage detailed mechanistic insights into drug
action. Modern drug discovery is guided by systems biology, high?throughput screening, and personalized medicine approaches, while regulatory pathways
now require robust evidence of safety, efficacy, and manufacturing quality.
Understanding pharmacokinetics, particularly absorption and metabolism, remains essential
for optimizing therapeutic regimens and ensuring patient safety.
---
References
"Drug Discovery & Development." National Institutes of Health, 2023.
"Pharmacokinetic Principles." FDA Guidance for Industry, 2019.
"Multi-Target Drug Design." Journal of Medicinal Chemistry,
vol. 65, no. 14, 2022, pp. 5431?5445.
"Personalized Medicine and Pharmacogenomics." Nature Reviews Drug Discovery, vol.
21, 2020.
[2025-09-26 02:11:27.609574]
URL
